Loading...
A frustrating component of pediatricians' practices is trying to use evidence-based medicine to guide the management of jaundice in newborns (JW Pediatr Adolesc Med Oct 21 2009). Most studies focus on preventing bilirubin encephalopathy and are often flawed. To develop a model for assessing the risk for subsequent hyperbilirubinemia, these authors conducted a retrospective, nested case-control study among 11,456 infants (gestational age, ≥35 weeks) who were discharged from a U.S. well-baby nursery from 2005 through 2007. The authors compared all 75 infants who had been readmitted for hyperbilirubinemia (transcutaneous bilirubin [TcB] measurement >17 mg/100 mL) and required phototherapy with 75 randomly selected controls who had not been rea…